“This applicator lets a surgeon control adhesive flow with one simple motion of the hand to start it, stop it, and start it again, all with complete precision. The glass ampoule is broken by the lever system and not by the surgeon’s fingers,” said David Kay, MD FAAOS, founder of Resivant Medical. “Combined with our high-viscosity, no-run adhesive, it gives clinicians a level of control during closure that simply hasn’t existed before.”
The patented design uses a pivoting lever that acts directly on the adhesive ampoule, generating controlled pressure to dispense adhesive when depressed and immediately halting flow when released. Paired with the Cutiva™ high-viscosity, no-run liquid adhesive, the applicator enables precise, intermittent dosing and clean, single-handed application that supports reliable wound closure, which are hallmarks of the Cutiva™ PLUS Skin Closure System. The System is cleared by the US FDA and is available and being used across the United States.